Researchers engineer "Nanotraps" that block SARS-CoV-2 infection
| Date | 3rd, Feb 2021 |
|---|---|
| Source | News Medical - Scientific News Websites |
DESCRIPTION
Researchers at Chicago University have developed an innovative new anti-SARS-CoV-2 therapy called “Nanotraps” – a family of nano-enabled virus-trapping particles – which have shown positive results in vitro, in vivo, and in human ex vivo trials.